
### [MONDO:0015859](http://purl.obolibrary.org/obo/MONDO_0015859)
**Label:** rare non-malformative uterovaginal or vulvovaginal disease

**Subclasses:** [MONDO:0015299](http://purl.obolibrary.org/obo/MONDO_0015299) (Asherman syndrome), [MONDO:0019370](http://purl.obolibrary.org/obo/MONDO_0019370) (vulvovaginal gingival syndrome), 

**Corr. equiv. classes:** [Orphanet:137686](http://www.orpha.net/ORDO/Orphanet_137686), [Orphanet:83453](http://www.orpha.net/ORDO/Orphanet_83453), 

**Class expressions from DL-Learner:**

- [HP:0011118](http://purl.obolibrary.org/obo/HP_0011118) (Abnormality of tumor necrosis factor secretion) 75.00%
- [HP:0011113](http://purl.obolibrary.org/obo/HP_0011113) (Abnormality of cytokine secretion) 75.00%
- [HP:0011118](http://purl.obolibrary.org/obo/HP_0011118) (Abnormality of tumor necrosis factor secretion) and [HP:0200041](http://purl.obolibrary.org/obo/HP_0200041) (Skin erosion) 75.00%
- [HP:0011118](http://purl.obolibrary.org/obo/HP_0011118) (Abnormality of tumor necrosis factor secretion) and [HP:0025142](http://purl.obolibrary.org/obo/HP_0025142) (Constitutional symptom) 75.00%
- [HP:0011118](http://purl.obolibrary.org/obo/HP_0011118) (Abnormality of tumor necrosis factor secretion) and [HP:0012537](http://purl.obolibrary.org/obo/HP_0012537) (Food intolerance) 75.00%
- [HP:0011118](http://purl.obolibrary.org/obo/HP_0011118) (Abnormality of tumor necrosis factor secretion) and [HP:0012531](http://purl.obolibrary.org/obo/HP_0012531) (Pain) 75.00%
- [HP:0011118](http://purl.obolibrary.org/obo/HP_0011118) (Abnormality of tumor necrosis factor secretion) and [HP:0012243](http://purl.obolibrary.org/obo/HP_0012243) (Abnormal reproductive system morphology) 75.00%
- [HP:0011118](http://purl.obolibrary.org/obo/HP_0011118) (Abnormality of tumor necrosis factor secretion) and [HP:0011830](http://purl.obolibrary.org/obo/HP_0011830) (Abnormality of oral mucosa) 75.00%
- [HP:0011118](http://purl.obolibrary.org/obo/HP_0011118) (Abnormality of tumor necrosis factor secretion) and [HP:0011368](http://purl.obolibrary.org/obo/HP_0011368) (Epidermal thickening) 75.00%
- [HP:0011118](http://purl.obolibrary.org/obo/HP_0011118) (Abnormality of tumor necrosis factor secretion) and [HP:0011355](http://purl.obolibrary.org/obo/HP_0011355) (Localized skin lesion) 75.00%
- [HP:0011118](http://purl.obolibrary.org/obo/HP_0011118) (Abnormality of tumor necrosis factor secretion) and [HP:0011354](http://purl.obolibrary.org/obo/HP_0011354) (Generalized abnormality of skin) 75.00%
- [HP:0011118](http://purl.obolibrary.org/obo/HP_0011118) (Abnormality of tumor necrosis factor secretion) and [HP:0011276](http://purl.obolibrary.org/obo/HP_0011276) (Vascular skin abnormality) 75.00%
- [HP:0011118](http://purl.obolibrary.org/obo/HP_0011118) (Abnormality of tumor necrosis factor secretion) and [HP:0011138](http://purl.obolibrary.org/obo/HP_0011138) (Abnormality of skin adnexa morphology) 75.00%
- [HP:0011118](http://purl.obolibrary.org/obo/HP_0011118) (Abnormality of tumor necrosis factor secretion) and [HP:0011122](http://purl.obolibrary.org/obo/HP_0011122) (Abnormality of skin physiology) 75.00%
- [HP:0011118](http://purl.obolibrary.org/obo/HP_0011118) (Abnormality of tumor necrosis factor secretion) and [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) 75.00%


